[DOI] [PubMed] [Google Scholar] 5.Gutierrez-Mariscal F.M., Yubero-Serrano E.M., Villalba J.M., Lopez-Miranda J
Nat Med 32 , 828840 (2026)
Retatrutide also produced a dysesthesia signal (8.820.9% at Phase 3 doses) the same new side effect now appearing with high-dose semaglutide, and its emergence in two separate next-generation drugs is a pattern worth watching
This approach strengthens the analytical toolkit to going beyond gold-standard techniques like IP-RPLC, enabling efficient tracking of both excipient- and peptide-related CQAs, which help to ensure overall drug product quality
By day 14, some mice showed a decrease in gap detection ratios, with no significant difference from the controls ( F 1,6 = 0.096, P = 0.767)
Variants in the GLP1R gene and FTO gene influence how strongly you respond to GLP-1 therapy and how aggressively your body fights weight loss through increased hunger hormones